Home HOME Neoplasma 2004 Neoplasma Vol.51, p.188-192, 2004

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.51, p.188-192, 2004

Title: Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells
Author: L., CIPAK ; H., PAULIKOVA ; L., NOVOTNY ; M., JAROSOVA ; P., RAUKO ;

Abstract: In this study we have examined the antitumor effect of combined administrations of indomethacin (IND) with doxorubicin (DOX) on growth of K-562 leukemia cells. Although, as single drug treatment, only high concentrations of IND reduced growth (>200 µM) and induced apoptosis (>800 µM) of the K-562 cells, a synergistic effects on DOX-induced cell growth inhibition, apoptosis and differentiation were observed during the co-administration of DOX with 10 µM IND. Cells treated with this combination had elevated GSHt level compare to DOX-treated cells. Modulation of GSHt level of DOX-treated cells with Cd2+ ions or BSO confirmed its important role in processes of DOX-induced differentiation. Results of this study showed that IND has a positive effect on therapeutic efficacy of DOX, and could be a perspective modulator in cancer chemotherapy.

Keywords: indomethacin, doxorubicin, GSH, apoptosis, differentiation, synergism
Year: 2004, Volume: 51, Issue: Page From: 188, Page To: 192

Price: 12.00 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.